Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-069277
Filing Date
2014-11-17
Accepted
2014-11-17 17:01:20
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v392876_10q.htm 10-Q 580307
2 EXHIBIT 31.1 v392876_ex31-1.htm EX-31.1 7703
3 EXHIBIT 31.2 v392876_ex31-2.htm EX-31.2 7990
4 EXHIBIT 32.1 v392876_ex32-1.htm EX-32.1 4332
5 EXHIBIT 32.2 v392876_ex32-2.htm EX-32.2 4369
  Complete submission text file 0001144204-14-069277.txt   10072365

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT imnp-20140930.xml EX-101.INS 1539684
7 XBRL TAXONOMY EXTENSION SCHEMA imnp-20140930.xsd EX-101.SCH 97510
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imnp-20140930_cal.xml EX-101.CAL 48780
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imnp-20140930_def.xml EX-101.DEF 531721
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE imnp-20140930_lab.xml EX-101.LAB 580970
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imnp-20140930_pre.xml EX-101.PRE 596493
Mailing Address CAMBRIDGE INNOVATION CENTER ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address CAMBRIDGE INNOVATION CENTER ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 914-606-3500
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

EIN.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36602 | Film No.: 141228540
SIC: 2834 Pharmaceutical Preparations